# Sole-Therapy Treatment of Atrial Fibrillation

> **NCT00566176** · PHASE2 · UNKNOWN · sponsor: **AtriCure, Inc.** · enrollment: 25 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DEVICE:** Surgical Ablation using the AtriCure Bipolar System

## Key facts

- **NCT ID:** NCT00566176
- **Lead sponsor:** AtriCure, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-10
- **Primary completion:** 2007-12
- **Final completion:** 2017-02
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2013-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00566176

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00566176, "Sole-Therapy Treatment of Atrial Fibrillation". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00566176. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*